Post Translational Modifications | (Microbial infection) Following infection by HIV-1, ubiquitinated by a cullin-5-RING E3 ubiquitin-protein ligase complex (ECS complex) hijacked by the HIV-1 Vif protein, leading to its degradation. |
Function | DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits antiviral activity against viruse such as HIV-1 or HIV-2. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA. Exhibits antiviral activity also against hepatitis B virus (HBV), equine infectious anemia virus (EIAV), xenotropic MuLV-related virus (XMRV) and simian foamy virus (SFV) and may inhibit the mobility of LTR and non-LTR retrotransposons. May also play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation. |
Protein Name | Dna Dc->Du-Editing Enzyme Apobec-3fApolipoprotein B Mrna-Editing Enzyme Catalytic Polypeptide-Like 3fA3f |
Cellular Localisation | CytoplasmP-Body |
Alternative Antibody Names | Anti-Dna Dc->Du-Editing Enzyme Apobec-3f antibodyAnti-Apolipoprotein B Mrna-Editing Enzyme Catalytic Polypeptide-Like 3f antibodyAnti-A3f antibodyAnti-APOBEC3F antibody |
Information sourced from Uniprot.org